Search
Search Constraints
You searched for: Journal Cancer letters Issue Volume 395(2017)Limit your search
- 616.994 8
- Cancer -- Periodicals 8
- Cancer -- Périodiques 8
- Electronic journals 8
- Neoplasms -- Periodicals 8
- Apoptosis -- Thyroid cancer -- BRAFV600E inhibitor -- Orthotopic model -- Bcl2 family protein 1
- BCLB -- Tumor suppressor gene -- Methylation -- Apoptosis -- Autophagy 1
- CAFs cancer-associated fibroblasts -- ECM extracellular matrix -- EGF epidermal growth factor -- ELISA enzyme-linked immunosorbent assay -- EMT epithelial–mesenchymal transition -- FGF fibroblast growth factor -- MMPs matrix metalloproteinases -- NSCLC non-small cell lung cancer -- PDGF platelet-derived growth factor -- PDGFR platelet-derived growth factor receptor -- qRT-PCR quantitative real-time reverse transcriptase-polymerase chain reaction -- rhPDGF-BB recombinant human platelet-derived growth factor BB -- TGFβ1 transforming growth factor β1 1
- CHK1 Checkpoint kinase 1 -- EGFR Epidermal growth factor receptor -- EMT Epithelial-to-mesenchymal transition -- HR Homologous recombination -- LIN7C Lin-7 homolog C -- miRNA microRNA -- NHEJ Non homologous end joining -- PCa Prostate cancer -- qRT-PCR Quantitative real-time polymerase chain reaction -- SCID Severe combined immunodeficiency -- siRNA Small interfering RNA -- ZEB1 Zinc finger E-box binding homeobox 1 1
- CM conditioned medium -- CSC cancer stem cell -- DMSO dimethyl sulfoxide -- EdU 5-ethynyl-2′-deoxyuridine -- EMT epithelial–mesenchymal transition -- EV endothelial vessel -- ERK extracellular signal-regulated kinase -- FAK focal adhesion kinase -- FBS fetal bovine serum -- GC gastric cancer -- HE hematoxylin and eosin -- HUVEC human umbilical vein endothelial cell -- HR hazard ratio -- IF immunofluorescence -- ISH in situ hybridization -- IHC immunohistochemistry -- lncRNA long non-coding RNA -- MALAT1 metastasis-associated lung adenocarcinoma transcript 1 -- MMP matrix metalloproteinase -- MT membrane type -- MTT 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide -- NC negative control -- OS overall survival -- PAS periodic acid-Schiff -- PFS progression-free survival -- VE vascular endothelial -- VM vasculogenic mimicry -- WB western blotting 1